Isolated fatty liver from prolonged propofol use in a pediatric patient with refractory status epilepticus

Clinical Neurology and Neurosurgery

Volumn 111, Issue 6, 2009, Pages 558-561

  Rison, Richard A ^a   Ko, David Y ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Fatty liver; Hepatomegaly; Lipophilic; Propofol; Propofol infusion syndrome; Refractory status epilepticus

Indexed keywords

DIAZEPAM; LORAZEPAM; MIDAZOLAM; PENTOBARBITAL; PHENOBARBITAL; PROPOFOL; VALPROIC ACID;

ADOLESCENT; ARTICLE; BLOOD SMEAR; BRAIN EDEMA; BRAIN HEMORRHAGE; CASE REPORT; CHILD CARE; COMPUTER ASSISTED TOMOGRAPHY; CONVULSION; DRUG REEXPOSURE; DRUG RESPONSE; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAPHY; EPILEPTIC STATE; FATTY LIVER; FEMALE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; LIVER BIOPSY; LIVER FUNCTION TEST; LUMBAR PUNCTURE; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; SEIZURE; SURGICAL TECHNIQUE; TREATMENT DURATION;

ADOLESCENT; ANTICONVULSANTS; FATTY LIVER; FEMALE; HUMANS; MIDAZOLAM; PROPOFOL; STATUS EPILEPTICUS; TIME FACTORS;

EID: 67349200271     PISSN: 03038467     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clineuro.2009.03.003     Document Type: Article

References (27)

1. Carli F., and Mistraletti G. Metabolic and endocrine effects of sedative agents. Miverva Anestesiologia 72 (2006) 395-399
2. Guitton J., Buronfosse T., Desage M., Flinois J.P., Perdrix J.P., Brazier J.L., and Beaune P. Possible involvement of multiple human cytochrome P450 isoforms in the liver metabolism of propofol. British Journal of Anaesthesia 80 6 (1998) 788-795
3. Kanto J., and Gepts E. Pharmacokinetic implications for the clinical use of propofol. Clinical Pharmacokinetics 17 5 (1989) 308-326
4. Astrazeneca. Letter to health care provider [online]. Available from URL: http://www.fda.gov/medwatch/safety/2001/diprivan_deardoc.pdf [accessed March 3, 2008].
5. Tiainen P., Lindgren L., and Rosenberg P.H. Disturbance of hepatocellular integrity associated with propofol anaesthesia in surgical patients. Acta Anaesthesiologica Scandinavica 39 6 (1995) 840-844
6. Motsch J., Schmidt H., Bach A., Bottiger B.W., and Bohrer H. Long-term sedation with propofol and green discoloration of the liver. European Journal of Anaesthesiology 11 6 (1994) 499-502
7. Lang H., Stephan H., Rieke H., Kellermann M., Sonntag H., and Bircher J. Hepatic and extrahepatic deposition of propofol in patients undergoing coronary bypass surgery. British Journal of Anaesthesiology 64 5 (1990) 563-570
8. Cray S.H., Robinson B.H., and Cox P.N. Lactic acidemia and bradyarrythmia in a child sedated with propofol. Critical Care Medicine 26 12 (1998) 1959-1960
9. Hanna J.P., and Ramundo M.L. Rhabdomyolysis and hypoxia associated with prolonged propofol infusion in children. Neurology 50 1 (1998) 301-303
10. Bray R.J. Propofol infusion syndrome in children. Pediatric Anaesthesia 8 (1998) 491-499
11. Fodale V., and La Monaca E. Propofol infusion syndrome: an overview of a perplexing disease. Drug Safety 31 4 (2008) 293-303
12. Kam P.C.A., and Cardone D. Propofol infusion syndrome. Anaesthesia 62 (2007) 690-701
13. Begemann M., Rowan A.J., and Tuhrim S. Treatment of refractory complex-partial status epilepticus with propofol: case report. Epilepsia 41 1 (2000) 105-109
14. Brown L.A., and Levin G.M. Role of propofol in refractory status epilepticus. Annals of Pharmacotherapy 32 10 (1998) 1053-1059
15. Stecker M.M., Kramer T.H., Raps E.C., O'Meeghan R., Dulaney E., and Skaar D.J. Treatment of refractory status epilepticus with propofol: clinical and pharmacokinetic findings. Epilepsia 39 1 (1998) 18-26
16. Harrison A.M., Lugo R.A., and Schunk J.E. Treatment of convulsive status epilepticus with propofol: case report. Pediatric Emergency Care 13 6 (1997) 420-422
17. Pitt-Miller P.L., Elcock B.J., and Maharaj M. The management of status epilepticus with a continuous propofol infusion. Anesthesia & Analgesia 78 6 (1994) 1193-1194
18. Servin F. Diprivan and liver. Annales Francaises d'Anesthesie et de Reanimation 13 4 (1994) 477-479
19. Ypsilantis P., Politou M., Mikroulis D., Pitiakoudis M., Lambropoulou M., Tsigalou C., Didilis V., Bougioukas G., Papadopoulos N., Manolas C., and Simopoulos C. Organ toxicity and mortality in propofol-sedated rabbits under prolonged mechanical ventilation. Anesthesia & Analgesia 105 July (1) (2007) 155-166
20. Baumeister F.A., Oberhoffer R., Leibhaber G.M., et al. Fatal propofol infusion syndrome in association with ketogenic diet. Neuropaediatrics 35 (2004) 250-252
21. Parke T.J., Stevens J.E., Rice A.S.C., Greenway C.L., Bray R.J., Smith P.J., Waldmann C.S., and Verghese C. Metabolic acidosis and fatal myocardial failure after propofol infusion in children: five case reports. British Medical Journal 305 (1992) 613-616
22. Ahlen K., Buckley C.J., Goodale D.B., and Pulsford A.H. The 'propofol infusion syndrome': the facts, their interpretation and implications for patient care. European Journal of Anaesthesiology 23 (2006) 990-998
23. Wolf A.W., and Potter F. Propofol infusion in children: when does an anesthetic tool become an intensive care liability?. Paediatric Anaesthesia 14 (2004) 425-428
24. Wolf A., Weir P., Segar P., Stone J., and Sheild J. Impaired fatty acid oxidation in propofol infusion syndrome. Lancet 357 (2001) 606-607
25. Kumar M.A., Urrutia V.C., Thomas C.E., et al. The syndrome of irreversible acidosis after prolonged propofol infusion. Neurocritical Care 3 (2005) 257-259
26. Kang T.M. Propofol infusion syndrome in critically ill patients. The Annals of Pharmacotherapy 36 (2002) 1453-1456
27. Hansen T.G. Propofol infusion syndrome in children. Ugeskrift for Laeger 167 (2005) 3672-3675